logo
episode-header-image
May 2023
7m 34s

Update on CAR-T Therapies in Acute and C...

European Hematology Association
About this episode
tail spinning
Up next
Jul 16
How to Start a Clinical Trial?
What does it take to design and lead a clinical trial in hematology? In this episode of EHA Unplugged, Prof. Elias K. Mai shares his experience transitioning from clinical practice to becoming a principal investigator, and how the EHA Clinical Research Training in Hematology (CRT ... Show More
18m 46s
Jul 3
How Experts Treat Multiple Myeloma
In this episode, Prof. Pieter Sonneveld is joined by Prof. Meletios Dimopoulos and Prof. Evangelos Terpos to discuss the updated EHA–EMN (European Myeloma Network) guidelines for the diagnosis, treatment and follow-up of multiple myeloma. The conversation explores how recent ther ... Show More
35m 39s
Jun 22
Where Are We Now With Immunotherapy in Multiple Myeloma?
Explore the latest advancements in immunotherapies for multiple myeloma, including CAR T-cell therapy, bispecific antibodies, and antibody-drug conjugates. In this episode, Dr. Paula Rodriguez Otero discusses the strategic sequencing of BCMA and explains why CAR-T cells should of ... Show More
22m 33s
Recommended Episodes
Aug 2024
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway
<p>How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024.<br />   <br /> Credit available for this activity expires: 07/31/25<br /> Earn Credit / Learning Obje ... Show More
37m 22s
Jun 2024
EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Lea ... Show More
33m 47s
Aug 2022
Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chimeric antigen receptor T-cell (CAR T) therapy, a validated novel therapeutic strategy in leukemic and lymphoid malignancies, continues to provid ... Show More
1h 30m
Dec 2024
263. Cytokines Everywhere All at Once: Approach to CRS and ICANS
Send us Fan MailAs a result of the rapid adoption CAR-T therapy for certain lymphoid malignancies and multiple myeloma, of these treatments, CRS and ICANS will become more common in IM wards in the coming years. Take a listen to learn about how to treat this emerging condition. T ... Show More
17m 17s
Aug 2025
Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson
In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma presented at the recent EHA and ICML meetings in June 2025. The episode focuses primarily on the emerging role of bispecific anti ... Show More
43m 3s
Oct 2025
179. Back to Basics - Metastatic NSCLC feat. EGFR and ALK Driver Mutations
In this episode, Michael and Josh take a dive into the world of driver mutations, looking at two of the most clinically consequential: EGFR and ALK mutations. The work done in these areas has led to treatments that represent incredible advances over chemotherapy. How incredible? ... Show More
24m 44s
Sep 2025
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ... Show More
24m 38s
Jul 2024
Season 4 Episode 7: Changing Treatment Landscape in IgAN and Disease Modification Approaches (supported by Vera Therapeutics)
For this episode of the Global Kidney Care Podcast, Jonathan Barratt, MD, MSc, PhD is Professor of Renal Medicine, Department of Cardiovascular Sciences at the University of Leicester and Richard Lafayette, MD, FACP is a Nephrologist and Professor of Medicine at the Division of N ... Show More
25m 13s